An upward trend in DNA P16INK4A methylation pattern and high risk HPV infection according to the severity of the cervical lesion;Padrão de metilação do gene P16INK4A e de infecções por HPV de alto risco acompanham a evolução de lesões cervicais

Revista do Instituto de Medicina Tropical de Sao Paulo

Volumn 55, Issue 5, 2013, Pages 329-334

  Carestiato, Fernanda Nahoum ^a   Afonso, Larissa Alves ^a   Moysés, Natalia ^a   Almeida Filho, Gutemberg Leão ^b   Velarde, Luis Guillermo Coca ^a   Cavalcanti, Silvia Maria Baeta ^a  

^a FLUMINENSE FEDERAL UNIVERSITY   (Brazil)

^b FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

Cervical cancer; HPV; Methylation; P16INK4A

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 2A;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER RISK; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE SEVERITY; DNA METHYLATION; FEMALE; GENE EXPRESSION; GENE FREQUENCY; GENETIC MARKER; GENOTYPE; HUMAN; HUMAN TISSUE; INFECTION RISK; MAJOR CLINICAL STUDY; P16INK4A GENE; PAPILLOMAVIRUS INFECTION; POLYMERASE CHAIN REACTION; RISK ASSESSMENT; TREND STUDY; UTERINE CERVICITIS; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA; UTERINE CERVIX EPITHELIUM;

ADULT; AGED; AGED, 80 AND OVER; CELL TRANSFORMATION, NEOPLASTIC; CERVICAL INTRAEPITHELIAL NEOPLASIA; CROSS-SECTIONAL STUDIES; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DNA METHYLATION; DNA, VIRAL; FEMALE; GENOTYPE; HUMANS; MIDDLE AGED; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; PRECANCEROUS CONDITIONS; SEVERITY OF ILLNESS INDEX; UTERINE CERVICAL NEOPLASMS; YOUNG ADULT;

EID: 84884163279     PISSN: 00364665     EISSN: 16789946     Source Type: Journal    
DOI: 10.1590/S0036-46652013000500006     Document Type: Article

References (26)

1. Burgers WA, Blanchon L, Pradhan S, Launoit YD, Kouzarides T, Fuks K. Viral oncoproteins target the DNA methyltransferases. Oncogene. 2007;26:1650-5.
2. Esteller M. Epigenetics in cancer. N Engl J Med. 2008;358:1148-59.
3. Feng Q, Balasubramanian A, Hawes SE, Toure P, Sow PS, Dem A, et al. Detection of hypermethylated genes in women with and without cervical neoplasia. J Natl Cancer Inst. 2005;97:273-82.
4. Fernandez AF, Rosales C, Lopez-Nieva P, Graña O, Ballestar E, Ropero S, et al. The dynamic DNA methylomes of double-stranded DNA viruses associated with human cancer. Genome Res. 2009;19:438-51.
5. Finzer P, Kuntzen C, Soto U, ZurHausen H, Rosl F. Inhibitors of histone deacetylase arrest cell cycle and induce apoptosis in cervical carcinoma cells circumventing human papillomavirus oncogene expression. Oncogene. 2001;20:4768-76.
6. Gustafson KS, Furth EE, Heitjan DF, Fansler ZB, Clark DP. DNA methylation profiling of cervical squamous intraepithelial lesions using liquid-based cytology specimens: an approach that utilizes receiver-operating characteristic analysis. Cancer. 2004;102:259-68.
7. Herman JG, Graff JR, Myohanen S, Nelkin BD, Baylin SB. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci. 1996;93:9821-6.
8. Jeong DH, Youm MY, Kim YN, Lee KB, Sung MS, Yoon HK, et al. Promoter methylation of p16, DAPK, CDH1, and TIMP-3 genes in cervical cancer: correlation with clinicopathologic characteristics. Int J Gynecol Cancer. 2006;16:1234-40.
9. Jones PA, Baylin SB. The fundamental role of epigenetic events in cancer. Nat Rev Genet. 2002;3:415-28.
10. Jones PA, Liang G. Rethinking how DNA methylation patterns are maintained. Nat Rev Genet. 2009;10:805-811.
11. Lea JS, Coleman R, Kurien A, Schorge JO, Miller DS, Minna JD, Aberrant p16 methylation is a biomarker for tobacco exposure in cervical squamous cell carcinogenesis. Am J Obstet Gynecol. 2004;190:674-9.
12. Narayan G, Arias-Pulido H, Koul S, Vargas H, Zhang FH, Villella J, et al. Frequent promoter methylation of CDH1, DAPK, RARB, and HIC1 genes in carcinoma of cervix uteri: its relationship to clinical outcome. Mol Cancer. 2003;2:1-12.
13. Nehls K, Vinokurova S, Schmidt D, Kommoss F, Reuschenbach M, Kisseljov F, et al. p16 methylation does not affect protein expression in cervical carcinogenesis. Eur J Cancer. 2008;44:2496-505.
14. Nuovo GJ, Plaia TW, Belinsky SA, Baylin SB, Herman JG. In situ detection of the hypermethylation induced inactivation of the p16 gene as an early event in oncogenesis. Proc Natl Acad Sci. 1999;96:12754-9.
15. Palmisano WA, Divine KK, Saccomanno G, Gilliland FD, Baylin SB, Herman JG, et al. Predicting lung cancer by detecting aberrant promoter methylation in sputum. Cancer Res. 2000;60:5954-8.
16. Sanchez-Cespedes M, Decker PA, Doffek KM, Esteller M, Westra WH, Alawi EA, et al. Increased loss of chromosome 9p21 but not p16 inactivation in primary non-small cell lung cancer from smokers. Cancer Res. 2001;61:2092-6.
17. Silva KC, Rosa MLG, Moyses N, Afonso LA, Oliveira LHS, Cavalcanti SMB. Risk factors associated with human papillomavirus infection in two populations from Rio de Janeiro, Brazil. Mem Inst Oswaldo Cruz. 2009;104:885-91
18. Solomon D, Davey D, Kuman R, Moriarty A, O'Connor D, Prey M, et al. The 2001 Bethesda System: terminology for reporting results of cervical cytology. JAMA. 2002;287:2114-9.
19. Spathis A, Aga E, Alepaki M, Chranioti A, Meristoudis C, Panayiotides I, et al. Promoter methylation of p16(INK4A), hMLH1, and MGMT in liquid-based cervical cytology samples compared with clinicopathological findings and HPV presence. Infect Dis Obstet Gynecol. 2011;2011:1-5.
20. Szalmás A, Kónya J. Epigenetic alterations in cervical carcinogenesis. Semin Cancer Biol. 2009;19:144-52.
21. Teng IW, Hou PC, Lee KD, Chu PY, Yeh KT, Jin VX, et al. Targeted methylation of two tumor suppressor genes is sufficient to transform mesenchymal stem cells into cancer stem/initiating cells. Cancer Res. 2011;71:4653-63.
22. Virmani AK, Muller C, Rathi A, Zoechbauer-Mueller S, Mathis M, Gazdar SF. Aberrant methylation during cervical carcinogenesis. Clin Cancer Res. 2001;7:584-9.
23. Wentzensen N, Sherman ME, Schiffman M, Wang SS. Utility of methylation markers in cervical cancer early detection: appraisal of the state-of-the-science. Gynecol Oncol. 2009;112:293-9.
24. WHO/ICO Information Centre on HPV and Cervical Cancer. Human papillomavirus and related cancers in Brazil. Summary Report, 2010. [cited 2010 May 12). Available from: www.who.int/hpvcentre
25. Wu MF, Cheng YW, Lai JC, Hsu MC, Chen JT, Liu WS, et al. Frequent p16INK4a promoter hypermethylation in human papillomavirus-infected female lung cancer in Taiwan. Int J Cancer 2005;113:440-5.
26. Yang B, Guo M, Herman JG, Clark DP. Aberrant promoter methylation profiles of tumor suppressor genes in hepatocellular carcinoma. Am J Pathol. 2003;163:1101-7.